Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
Public ClinicalTrials.gov record NCT02877927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Oral Omadacycline to Oral Linezolid for Treating Adult Subjects With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Study identification
- NCT ID
- NCT02877927
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Paratek Pharmaceuticals Inc
- Industry
- Enrollment
- 735 participants
Conditions and interventions
Interventions
- Linezolid Drug
- Omadacycline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2016
- Primary completion
- May 25, 2017
- Completion
- Jun 5, 2017
- Last update posted
- Nov 29, 2018
2016 – 2017
United States locations
- U.S. sites
- 50
- U.S. states
- 15
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 620 | Birmingham | Alabama | 35215 | — |
| Site 642 | Mobile | Alabama | 36608 | — |
| Site 616 | Anaheim | California | 92801 | — |
| Site 601 | Anaheim | California | 92804 | — |
| Site 636 | Bakersfield | California | 93301 | — |
| Site 606 | Buena Park | California | 90620 | — |
| Site 604 | Chula Vista | California | 91911 | — |
| Site 659 | Huntington Beach | California | 92647 | — |
| Site 608 | La Mesa | California | 91942 | — |
| Site 618 | Laguna Hills | California | 92653 | — |
| Site 612 | Long Beach | California | 90813 | — |
| Site 648 | Modesto | California | 95350 | — |
| Site 610 | Oceanside | California | 92056 | — |
| Site 615 | San Diego | California | 92114 | — |
| Site 621 | San Diego | California | 92119 | — |
| Site 613 | San Francisco | California | 94115 | — |
| Site 603 | Stockton | California | 95204 | — |
| Site 650 | Torrance | California | 90502 | — |
| Site 646 | Ventura | California | 93003 | — |
| Site 614 | DeLand | Florida | 32720 | — |
| Site 655 | Fort Myers | Florida | 33901 | — |
| Site 656 | Homestead | Florida | 33030 | — |
| Site 631 | Miami | Florida | 33015 | — |
| Site 658 | Miami | Florida | 33125 | — |
| Site 654 | Miami | Florida | 33134 | — |
| Site 626 | Miami | Florida | 33144 | — |
| Site 637 | Miami | Florida | 33144 | — |
| Site 653 | Miami | Florida | 33145 | — |
| Site 641 | Miami | Florida | 33175 | — |
| Site 645 | Miami | Florida | 33175 | — |
| Site 640 | Miami Lakes | Florida | 33016 | — |
| Site 662 | Miami Lakes | Florida | 33104 | — |
| Site 609 | Saint Cloud | Florida | 34769 | — |
| Site 644 | Council Bluffs | Iowa | 51503 | — |
| Site 657 | Boston | Massachusetts | 02115 | — |
| Site 617 | St Louis | Missouri | 63128 | — |
| Site 602 | Butte | Montana | 59701 | — |
| Site 623 | Las Vegas | Nevada | 89109 | — |
| Site 630 | Somers Point | New Jersey | 08244 | — |
| Site 647 | Jackson Heights | New York | 11372 | — |
| Site 632 | Mount Airy | North Carolina | 27030 | — |
| Site 649 | Toledo | Ohio | 43608 | — |
| Site 607 | Rapid City | South Dakota | 57702 | — |
| Site 635 | Jackson | Tennessee | 38305 | — |
| Site 628 | Smyrna | Tennessee | 37167 | — |
| Site 633 | Baytown | Texas | 77521 | — |
| Site 605 | Channelview | Texas | 77530 | — |
| Site 625 | Houston | Texas | 77008 | — |
| Site 627 | Houston | Texas | 77084 | — |
| Site 634 | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02877927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 29, 2018 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02877927 live on ClinicalTrials.gov.